基质特异性化作用 通过细胞染色体b5增强CYP17A1酶效率
在PubMed上查看摘要
概括
此摘要是机器生成的。细胞染色体b5通过重定向基质键,特别是17OH- 孕激素,以全增强CYP17A1酶的活性. 这解释了酶
科学领域
- 生物化学
- 酵素学
- 类固醇生成
背景情况
- CYP17A1是人类类固醇激素生产中的关键酶.
- 细胞染色体b5 (Cyt b5) 显著增强了CYP17A1的C17- C20酶活性.
- 对于Cyt b5刺激的机制,尤其是17OH- 孕 (17OH- PROG) 的作用,尚不清楚.
研究的目的
- 为了阐明Cyt b5刺激CYP17A1酶活性的全性机制.
- 将Cyt b5对CYP17A1的影响与不同类固醇基质进行比较.
主要方法
- 使用共振拉曼光谱来研究CYP17A1的氧复合物.
- 将CYP17A1和Mn替代的Cyt b5 (Mn-Cyt b5) 纳入脂质纳米盘中.
- 分析了基板引起的Fe-O振动模式的变化.
主要成果
- Mn-Cyt b5诱导了17OH-PROG的Fe-O模式的特定转移,表明了改变的键.
- 这种转变表明17OH组对Fe-O-O部分的偏向有利,促进了酶活性.
- 即使没有Mn-Cyt b5,17OH-pregnenolone也表现出这种有利的方向.
结论
- 提供了Cyt b5对17OH-PROG催化增强的精确代解释.
- 证明Cyt b5能积极重定向与基质结合的水或基质基,以优化催化.
- 突出了由Cyt b5对CYP17A1活性进行的基质特异调节.
相关概念视频
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

